These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38610138)
21. Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada. Broad J; Mason K; Guyton M; Lettner B; Matelski J; Powis J Int J Drug Policy; 2020 Jun; 80():102755. PubMed ID: 32416538 [TBL] [Abstract][Full Text] [Related]
22. Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark. Demant J; Krohn-Dehli L; Van der Veen J; Øvrehus A; Lazarus JV; Weis N Int J Drug Policy; 2023 Nov; 121():104185. PubMed ID: 37774576 [TBL] [Abstract][Full Text] [Related]
23. High Satisfaction with Patient-Centered Telemedicine for Hepatitis C Virus Delivered to Substance Users: A Mixed-Methods Study. Talal AH; Sofikitou EM; Wang K; Dickerson S; Jaanimägi U; Markatou M Telemed J E Health; 2023 Mar; 29(3):395-407. PubMed ID: 35925809 [No Abstract] [Full Text] [Related]
24. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883 [TBL] [Abstract][Full Text] [Related]
25. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia. Coupland H; White B; Bates A; Park JN; Iversen J; Maher L Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363 [TBL] [Abstract][Full Text] [Related]
26. An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study. Allan LM; Wheatley A; Smith A; Flynn E; Homer T; Robalino S; Beyer FR; Fox C; Howel D; Barber R; Connolly JA; Robinson L; Parry SW; Rochester L; Corner L; Bamford C Health Technol Assess; 2019 Oct; 23(59):1-208. PubMed ID: 31661058 [TBL] [Abstract][Full Text] [Related]
27. Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation. Corneli A; Perry B; Des Marais A; Choi Y; Chen H; Lilly R; Ayers D; Bennett J; Kestner L; Meade CS; Sachdeva N; McKellar MS Harm Reduct J; 2022 Dec; 19(1):132. PubMed ID: 36463214 [TBL] [Abstract][Full Text] [Related]
28. A contactless cure: Leveraging telehealth to improve hepatitis C treatment at a safety-net hospital. Frye K; Davis A; Darby R; McDaniel K; Quairoli K; Liu Z; Miller LS; Fluker SA J Viral Hepat; 2024 Apr; 31(4):176-180. PubMed ID: 38369695 [TBL] [Abstract][Full Text] [Related]
29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
30. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service. Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851 [TBL] [Abstract][Full Text] [Related]
31. Healthcare Workers' Knowledge and Attitude Toward Telemedicine During the COVID-19 Pandemic: A Global Survey. Naqvi SZ; Ahmad S; Rocha IC; Ramos KG; Javed H; Yasin F; Khan HD; Farid S; Mohsin A; Idrees A Cureus; 2022 Oct; 14(10):e30079. PubMed ID: 36381792 [TBL] [Abstract][Full Text] [Related]
32. A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences. Karasz A; Merchant K; Arnsten J; Feinberg J; Kim AY; Lum PJ; McKee MD; Mehta SH; Meissner P; Norton BL; Page K; Pericot-Valverde I; Singh R; Stein E; Taylor LE; Tsui JI; Wagner K; Litwin A J Med Internet Res; 2023 Jun; 25():e38176. PubMed ID: 37266986 [TBL] [Abstract][Full Text] [Related]
33. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India. Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS Elife; 2021 Aug; 10():. PubMed ID: 34342266 [TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
35. A Cross-Sectional Survey on the Post-Pandemic Acceptability of Pharmacist-Delivered Telehealth Services Among HCV-HIV Patients. Mayaka RK; Awuonda MK; Ettienne E; Daftary M; Wingate L; Unonu J Inquiry; 2023; 60():469580231171338. PubMed ID: 37232384 [TBL] [Abstract][Full Text] [Related]
36. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene. Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571 [TBL] [Abstract][Full Text] [Related]
37. Assessing differences in contraceptive provision through telemedicine among reproductive health providers during the COVID-19 pandemic in the United States. Comfort AB; Rao L; Goodman S; Raine-Bennett T; Barney A; Mengesha B; Harper CC Reprod Health; 2022 Apr; 19(1):99. PubMed ID: 35459218 [TBL] [Abstract][Full Text] [Related]
38. Critical Care Network in the State of Qatar. Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205 [TBL] [Abstract][Full Text] [Related]
39. Barriers and facilitators: Clinicians' opinions and experiences of telehealth before and after their use of a telehealth platform for child language assessment. Sutherland R; Hodge A; Chan E; Silove N Int J Lang Commun Disord; 2021 Nov; 56(6):1263-1277. PubMed ID: 34455670 [TBL] [Abstract][Full Text] [Related]
40. Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research. Abadie R; Goldenberg S; Welch-Lazoritz M; Fisher CB PLoS One; 2018; 13(12):e0208410. PubMed ID: 30517202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]